U.S. FDA proposes ending use of popular decongestant present in cold medicines
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...
Hosted on MSN3d
Should Kids Get the COVID-19 Vaccine?
Children shouldn't receive the Moderna or Pfizer-BioNTech vaccines if they've had a severe allergic reaction to the ...
Yahoo18h
Frontier Airlines pilots picket as contract negotiation continue to stall
DENVER (KDVR) — Pilots at Frontier Airlines spent Tuesday afternoon picketing in front of the company’s Denver headquarters ...
pharmaphorum2d
Novavax confirms efficacy of COVID-19 jab against UK variant
A clinical trial has found that Novavax’ COVID-19 vaccine is 86% protective against the UK variant of SARS-CoV-2, only slightly lower than the 96% efficacy seen with the original strain of the ...
Yahoo Finance1d
India Pet Food Market Report 2024: Value to Double to $1.98 Billion - Competitive Landscape, Forecasts and Opportunities, 2020-2030F
Organic options, made from ingredients grown without synthetic pesticides or fertilizers, are also gaining popularity among ...
Yahoo Finance6d
Why Is COVID-19 Vaccine Maker Novavax Stock Trading Lower On Wednesday?
On November 1, Novavax, Inc. (NASDAQ:NVAX) and the U.K. Health Security Agency, representing the U.K. Secretary of State for Health and Social Care, signed a Termination and Settlement Agreement ...
BioSpace2d
UPDATE: FDA Lifts Clinical Hold on Novavax’s COVID/Flu Vaccine Candidates, Clears Phase III Trial
A trial participant developed amytrophic lateral sclerosis (ALS), an event deemed unrelated to vaccination. Novavax’s shares jumped in pre-market trading on the news but settled once markets opened.
MarketWatch4d
Novavax Inc.
Inovio Pharmaceuticals Inc.-3.56% $138.65M ...
precisionvaccinations4d
Precision Vaccinations
Eliminating fake vaccine news with pharmacist, nurse, and physician review.